Pulmonx Share Price

Pulmonx Share Price

NASDAQ: LUNG | Micro Cap | Healthcare
$2.58
-$0.16 (-5.84%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Pulmonx Stock Performance

Open
$2.73
Prev. Close
$2.74
Circuit Range
N/A
Day Range
$2.52 - $2.79
Year Range
$1.14 - $3.22
Volume
80,659
Average Traded
$2.62

Pulmonx Share Price Today

As of 22 November 2026, Pulmonx Corporation's share price is $2.58. The stock opened at $2.73, compared to its previous close of $2.74. During today's trading session, Pulmonx Corporation's share price traded between $2.52 and $2.79, with an average price of $2.66. Over the past 52 weeks, the stock has recorded a high of $3.22 and a low of $1.14. In terms of performance, Pulmonx Corporation's share price has risen by 55.42% over the last six months and is up 56.84% on a year-on-year basis.

Pulmonx Share Price Chart

Line chart of the Pulmonx price trend over the selected period. The price fell overall, ranging from 2.53 to 2.81, ending at 2.58.
$2.52$2.79
L
Show Current Price
H

Pulmonx Stock Fundamentals & Key Indicators

Market Cap
$104.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.98
Revenue (TTM)
$90.50B
Return On Equity (TTM)
-124.42%
Profit Margin
-59.67%
Debt to Equity
1.11
Quarterly Earnings Growth YoY
19.56%

Pulmonx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$22.60$20.59$22.76$22.84
Net Profit-$10.43-$13.65-$10.08-$8.39
Net Profit Margin-46.15%-66.29%-44.29%-36.73%
Income ChangeN/A-30.87%26.15%16.77%

Pulmonx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$53.66$68.68$83.79$90.50
Net Profit-$58.92-$60.84-$56.39-$54.00
Net Profit Margin-109.80%-88.58%-67.30%-59.67%
Income ChangeN/A-3.26%7.31%4.24%

Pulmonx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets27.6126.627.3624.72
Current Assets101.68136.25150.42168.95
Total Assets129.29162.85177.78193.68
Non Current Liabilities55.1252.636.3121.18
Current Liabilities20.0624.4423.1618.49
Total Liabilities75.1877.0459.4739.67
Shareholders' Equity54.1285.81118.32154.01

Pulmonx Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-32.38-31.54-37.61-45.08
Investing30.4817.48-0.82-2.28
Financing0.831.3620.220.48

About Pulmonx

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Pulmonx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.06
$2.56
-13.07%
Oct 2026
$1.92
$2.94
+52.99%
Sep 2026
$2.36
$1.93
-20.78%
Aug 2026
$1.71
$2.43
+50.00%
Jul 2026
$1.30
$1.62
+25.10%
Jun 2026
$1.64
$1.29
-21.99%
May 2026
$1.34
$1.66
+29.69%
Apr 2026
$1.30
$1.28
-0.78%
Mar 2026
$1.49
$1.29
-18.35%
Feb 2026
$1.65
$1.58
-3.07%
Jan 2026
$2.21
$1.63
-26.24%
Dec 2025
$1.64
$2.21
+34.35%

Pulmonx Share Price FAQs